Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension.
about
EndothelinPlasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertensionEndothelin and its antagonists in hypertension: can we foresee the future?The effects of ethnic discrimination and socioeconomic status on endothelin-1 among blacks and whites.Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence.Endothelin receptor antagonists: novel agents for the treatment of hypertension?Endothelin-1 response to glucose and insulin among African AmericansRole of endothelin in human hypertension.Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.Differences in hypertension between blacks and whites: an overview.An update on the status of endothelin receptor antagonists for hypertension.Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.Participation of renal and circulating endothelin in salt-sensitive essential hypertension.Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatmentCirculating endothelin-1 alters critical mechanisms regulating cerebral microcirculationThe therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.Endothelin and the podocyteDifferential Impact of Stress Reduction Programs upon Ambulatory Blood Pressure among African American Adolescents: Influences of Endothelin-1 Gene and Chronic Stress Exposure.Regulation of blood pressure and salt homeostasis by endothelin.TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 RatsThe potential of endothelin antagonism as a therapeutic approach.Heart failure--the importance of ethnicity.Differential Post-Exercise Blood Pressure Responses between Blacks and CaucasiansTherapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy.Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease.The Association of Endothelin-1 with Markers of Arterial Stiffness in Black South African Women: The SABPA Study.Racial disparities in outcomes following coronary artery bypass grafting.Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.Endothelin-receptor antagonists in arterial hypertension: further indications?Interactive influences of ethnicity, endothelin-1 gene, and everyday discrimination upon nocturnal ambulatory blood pressure.Physiology of endothelin and the kidney.Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening.Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension.Plasma endothelin-1 is not increased in overweight/obese hypertensive African women.Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis.Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.Low levels of plasma endothelin-1 in patients with retinitis pigmentosa.Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.Hypertension and end-organ disease in African Americans: case presentations.
P2860
Q26767156-A8A55F4E-F193-4F75-A3D2-5FA99E8C2C5DQ30477319-1B9024E2-C3FA-4D86-AB92-DB39735D6F3DQ30612015-C286E34B-3ABE-49DF-BD7B-BCA097532758Q33611318-AD1D110A-AECC-44D0-A728-1BD9DAFECD9BQ34028499-05AE46AB-359E-432B-AA4B-F97D43523A2AQ34119541-1F6D620A-6C4E-4510-8B99-D0489A7DB509Q34195357-575911A3-9221-41CD-9FF5-F0F43514219EQ34210942-CCE26D36-7713-46AF-A138-690BC1EBE135Q34213510-FA1A0638-0747-45C5-994E-DC111896CFC8Q34220023-8427F36C-DA3B-45B4-ACF7-70E7921283EDQ34481817-31DC7BF7-BB41-4234-90D4-DCFA02CDB9DEQ34496108-861BC23F-4F64-4E68-94C0-877F75153165Q34702439-ACE3750A-4901-4813-80B3-ED4C3FB6C977Q34727876-9B7DC7BD-7851-42C9-8DE4-8DB7A18C51CAQ34957350-6054117A-B563-44C7-951A-35D454FE2C35Q35001002-8EBC096B-DF10-4621-8F72-BCF7C673CD49Q35113482-ABDB4EE7-75F2-484B-B96F-D5DF7F54DB3CQ35452282-610F22C6-F3BB-4103-814D-668590E1CEDEQ35582485-4FC65E51-C3B1-4E8F-BC87-16B08D3F0FE0Q35609851-9AB42AB8-A48E-4685-AD4F-54AD46F8E13EQ35660077-94A8ECAD-36E9-4D56-B3DD-7AD5B616B367Q35925573-8F06F923-A0A9-4C74-BE22-272A73CB7044Q35958227-417809BF-0C54-427F-BF1D-7ECD87D3A9C3Q35988524-75307413-FB27-4317-8C21-2C6F37AC5BF6Q36109569-FD7F1095-B548-4057-A920-6A0DFA2D62D5Q36361625-BE7F55A4-AB28-4D27-A42E-5417AE7E69DAQ36448456-5C42E4C7-0FDF-44AB-BFC6-4F60F10A9B98Q36591132-CE8F93BB-6DFF-44B1-90B7-6684ADACA1A3Q36675400-B56D1FB8-BCB4-40C0-BD74-3268AB8DA617Q36760532-49EF29FD-EBB3-4BDA-B2FB-F4EB0F205010Q36815302-9052BC3E-30E5-43E2-A6EA-2386A2332067Q37613679-62166896-0F05-4053-90F6-FB6FBB3F2B18Q38191192-25B8511F-1A53-490A-8765-9B61AC81C9F3Q38225794-00376ADF-28CD-4D3F-B169-DEE2E7FDD3B0Q38319350-B3F47187-65CD-4D10-BC09-6F69D9D4C0F1Q40065488-AA6EA897-C740-41D3-83B2-DAB7AD79C614Q40161365-B85E3D5A-1BE5-46E9-A9C2-06A0599D24D4Q41829825-B24FC7CA-0310-4997-9975-8F1F79C02D4EQ44473667-A8590CD6-54B0-4C60-9F92-72BA078791FCQ44901702-8CB8DF29-48D6-4AA9-940B-0F4B11ABB29A
P2860
Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Racial differences in plasma e ...... s with essential hypertension.
@ast
Racial differences in plasma e ...... s with essential hypertension.
@en
Racial differences in plasma e ...... s with essential hypertension.
@nl
type
label
Racial differences in plasma e ...... s with essential hypertension.
@ast
Racial differences in plasma e ...... s with essential hypertension.
@en
Racial differences in plasma e ...... s with essential hypertension.
@nl
prefLabel
Racial differences in plasma e ...... s with essential hypertension.
@ast
Racial differences in plasma e ...... s with essential hypertension.
@en
Racial differences in plasma e ...... s with essential hypertension.
@nl
P2093
P356
P1433
P1476
Racial differences in plasma e ...... s with essential hypertension.
@en
P2093
P304
P356
10.1161/01.HYP.28.4.652
P407
P577
1996-10-01T00:00:00Z